A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries

Frye, LJ; Kilfedder, C; Blum, J; Winikoff, B.
Contraception ; 101(5): 315-320, May 2020.
Artigo em Inglês | MMyP | ID: biblio-1127858

Documentos relacionados

  1. A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries.
  2. Warning labels on alcoholic beverage containers: a pilot randomized experiment among young adults in Mexico.
  3. Approved but Unavailable: A Mystery-Caller Survey of Mifepristone Access in a Large Ontario City.
  4. Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits.
  5. Efficacy and safety of medical termination of pregnancy in a regional primary care setting.
  6. Medical management of early pregnancy loss is cost-effective compared with office uterine aspiration.
  7. Medical treatment for early fetal death (less than 24 weeks).
  8. Medical Termination of Pregnancy (MToP) in the 1st trimester - the role of human chorionic gonadotropin and ultrasound in pregnancy diagnosis and MToP follow-up.
  9. Analysis of the Clinical Efficacy of Conservative Treatment for an Unruptured Cornual Pregnancy.
  10. Cervical preparation for second-trimester procedural abortion.